https://www.lezdotechmed.com/blog/product-liability/pharma-lawsuits/
America spent about $576.9 billion on prescription pharmaceuticals in 2021, and sales are predicted to rise by four to six percent in 2022. The United States makes over $148 billion from the sale of medical equipment alone, making up nearly half of the global pharmaceutical market share, according to the United States Department of Commerce. Along with that the number of pharma lawsuits are also on the rise.
Design, production, or marketing are the three stages during which a product might have flaws. Pharmaceutical corporations can undermine the components of a medicine or medical device's safety through design flaws. When the production process does not adhere to the design specifications, manufacturing faults result. When manufacturers fail to disclose dangers or purposefully conceal problems, marketing faults result.
In recent decades, there has been a steady stream of cases in the US involving prescription drugs. Many of these lawsuits may be unknown to the majority of people. Knowing them will help you avoid being a victim. Numerous of these have contributed to the opioid crisis in America.
Interstitial cystitis (IC), commonly known as painful bladder syndrome (PDS), is a condition that results in throbbing pain, swelling of the bladder and pelvis, ulceration, and bleeding. Elmiron is a prescription drug used to treat IC. The macula, a region of the retina that can result in vision loss and blindness, is allegedly affected by maculopathy, an eye ailment, according to the lawsuit.
A medication called Jardiance aids those with type 2 diabetes in controlling their blood sugar levels. This prescription medication can increase the chance of acquiring Fournier's gangrene when combined with Farixga. The pharmaceutical allegedly failed to warn patients about this risk, according to the claims.
By treating blood clots, the blood thinner Pradaxa helps to avoid strokes. Sadly, this prescription medication has been associated with numerous tragic incidents of catastrophic hemorrhage. Due to Pradaxa, the German pharmaceutical business and medicine maker Boehringer Ingelheim was the target of numerous wrongful death claims.
The class of drugs known as proton pump inhibitors includes Nexium, Protonix, Prilosec, and Prevacid. Acute interstitial nephritis, sometimes known as AIN, and renal injury and failure are all conditions that are attributed to PPIs in legal cases.
A prescription drug called tenofovir/Truvada is used to treat hepatitis B and HIV infections. This medication damaged some patients' bones and caused kidney issues. Gilead Sciences, the product's maker, was aware of the risk yet did not take it off the market.
High blood pressure is treated with the prescription medication valsartan. According to the latest case, N-nitrosodimethylamine was discovered in numerous batches of valsartan and is responsible for stomach, liver, and kidney cancer.
Zantac is a medication used to treat and prevent heartburn. Additionally, it can be used to treat gastric reflux illness and stomach ulcers (GERD). Zantac has been shown to contain NDMA, which results in cancer of the bladder, stomach, esophagus, liver, and pancreas. Despite being aware of the risks, the manufacturer did not alert customers.
In almost 109,000 allegations, transvaginal mesh has been blamed for causing autoimmune illnesses, organ failure, bleeding, discomfort, and infections. One of the largest transvaginal mesh settlements to date was $830 million and covered 20,000 cases.
IVC filters were developed for those who struggle to take their anticoagulant medicine as prescribed because they are bleeding or are at high risk of bleeding. IVC filter failure can result in pulmonary embolism (PE), death, caval thrombosis, caval perforation, filter embolization, filter migration, and filter fracture.
After surgery, a medical device called hernia mesh is utilized to support the tissues that are mending around the location of the excised hernia. The complaints contend that the implant devices were improperly constructed and that the manufacturers failed to warn patients of potential risks and adverse reactions include swelling, severe scarring, nerve damage, and mesh shrinkage.
The majority of the biggest payouts in drug industry lawsuits to date have centred on how businesses misrepresented medications and their uses to doctors. Drug companies pushed their drugs for applications that were not FDA-approved, which led to the filing of several of these pharma lawsuits.
